Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations
- 1 April 1994
- journal article
- review article
- Published by Springer Nature in Human Genetics
- Vol. 93 (4) , 364-368
- https://doi.org/10.1007/bf00201659
Abstract
Cystic fibrosis is a common, fatal disorder caused by abnormalities in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. CFTR encodes a chloride channel that regulates secretion in many exocrine tissues. The presentation of cystic fibrosis is highly variable as measured by the age of onset of disease, the presence of pancreatic insufficiency, or the progression of lung disease. Over 400 mutations in the CFTR gene have been described in cystic fibrosis patients and considerable effort has focused on the correlation between specific mutations and genotypes and clinical characteristics. Individual tissues display variation in their sensitivity to CFTR mutations. The vas deferens is functionally disrupted in nearly all males, whereas mild and severe pancreatic involvement is determined by the patient's genotype. The severity of pulmonary disease is poorly correlated with genotype, suggesting that there are other important genetic and/or environmental factors that contribute to lung infections and the subsequent disruption of lung function.Keywords
This publication has 41 references indexed in Scilit:
- High Frequency of the R117H Cystic Fibrosis Mutation in Patients with Congenital Absence of the Vas DeferensNew England Journal of Medicine, 1993
- Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosisThe Lancet, 1993
- Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitiveNature, 1992
- Genetic determination of exocrine pancreatic function in cystic fibrosis.1992
- Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease.1992
- Severity of cystic fibrosis in patients homozygous and heterozygous for ΔF508 mutationThe Lancet, 1991
- Worldwide survey of the delta F508 mutation--report from the cystic fibrosis genetic analysis consortium.1990
- Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic miceNature, 1990
- Identification of the Cystic Fibrosis Gene: Chromosome Walking and JumpingScience, 1989
- Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNAScience, 1989